Erectile dysfunction (ED), also known as impotence, is the inability to acquire and maintain an erect penis. ED is a very common condition, particularly in older men where it is estimated half of all men between the ages of 40 and 70 suffer from ED to some degree. ED is linked to many causes, such as psychological, hormonal and vascular factors. Genetic factors are also suspected in about one-third of erectile dysfunction cases, however, it has proved difficult for researchers to identify any specific genomic locations. Now, a study from researchers led by Kaiser Permanente isolates a specific place in the human genome where variations can raise a person’s risk of erectile dysfunction. The team states their study highlights the potential of SIM1 as a target for the development of new treatments for ED, needed in approximately 50% of men unresponsive to current ED therapeutics. The opensource study is published in the journal PNAS.
Previous studies show ED is a common condition of men in middle and older ages and tied to psychosocial, neurological, hormonal, and vascular factors. A twin study in middle-aged male veterans found about one-third of the risk is heritable due to genetic factors, independent of other known erectile dysfunction risk factors. However, studies involving specific genetic contributors have been limited due to small sample sizes, candidate gene approaches, and weak phenotyping. As a result, there are no confirmed genetic risk factors for ED. The current study identifies variations in a specific place in the genome, near the SIM1 gene, significantly associated with an increased risk of ED.
The current study investigates medical records and DNA samples from 36,649 men in the Kaiser Permanente GERA cohort to identify a genomic region, or locus, associated with ED risk. The group also validated these results in a second study cohort, based on records and DNA from 222,358 men in the U.K. Biobank. Results show variations in the locus near the SIM1 gene are significantly associated with an increased risk of erectile dysfunction, with all other known risk factors for ED ruled out. Data findings show variations in the SIM1 locus are associated with a 26% increased risk of ED.
The lab explains the SIM1 gene is an established part of a signaling pathway known to play a central role in body weight regulation and sexual function with the ED loci located near the SIM1 gene. They go on to add they show the ED loci physically interacts with the promoter of the SIM1 gene to alter the function of a master gene regulator, called an enhancer. They conclude as the ED risk locus shows enhancer activity and interacted with the SIM1 promoter, the ED risk locus likely influences the expression of the SIM1 gene, turning it on and off when needed.
The team surmises they have identified a specific genetic cause for ED. For the future, the researchers state their study could help identify other key genetic variants triggering ED.
Source: Kaiser Permanente
Get Healthinnovations delivered to your inbox:
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.